Yangping Wu
Impact in
- Cell Biology top 5%
- Microtubule and mitosis dynamics
- Cellular Mechanics and Interactions
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 11
- Cancer Immunotherapy and Biomarkers 4
- Colorectal Cancer Treatments and Studies 2
- HER2/EGFR in Cancer Research 2
-
- Microtubule and mitosis dynamics 4
- Co-authors
- Xi Chen (14 shared papers)Jinliang Yang (11 shared papers)Yuxi Wang (7 shared papers)Qian Lei (3 shared papers)Weimin Li (3 shared papers)Qinhuai Lai (4 shared papers)Benoı̂t Gigant (2 shared papers)Qiang Chen (3 shared papers)
- Journals
- Journal of Molecular Medicine (3 papers)Molecular Cancer (2 papers)Signal Transduction and Targeted Therapy (2 papers)Frontiers in Immunology (2 papers)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Yangping Wu
27 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 80
- Cell Biology 234
- Oncology 234
- Cancer Research 99
- Organic Chemistry 226
- Molecular Biology 400
Countries citing papers authored by Yangping Wu
This map shows the geographic impact of Yangping Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangping Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangping Wu more than expected).
Fields of papers citing papers by Yangping Wu
This network shows the impact of papers produced by Yangping Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangping Wu. The network helps show where Yangping Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangping Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 215 | |
| 2 | 2015 | 198 | |
| 3 | 2019 | 146 | |
| 4 | 2020 | 95 | |
| 5 | 2010 | 78 | |
| 6 | 2017 | 73 | |
| 7 | 2015 | 69 | |
| 8 | 2017 | 64 | |
| 9 | 2016 | 45 | |
| 10 | 2015 | 44 | |
| 11 | 2021 | 43 | |
| 12 | 2023 | 40 | |
| 13 | 2017 | 37 | |
| 14 | 2019 | 34 | |
| 15 | 2021 | 34 | |
| 16 | 2012 | 32 | |
| 17 | 2014 | 30 | |
| 18 | 2023 | 16 | |
| 19 | A novel 5T4-targeting antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy in gastrointestinal tumor xenograft models. | 2018 | 15 |
| 20 | 2013 | 14 |
About Yangping Wu
Yangping Wu is a scholar working on Oncology, Cell Biology, Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Microtubule and mitosis dynamics (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Extracellular vesicles in disease (2 papers), Circular RNAs in diseases (2 papers), HER2/EGFR in Cancer Research (2 papers) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Cell Biology (234 citations), Oncology (234 citations), Cancer Research (99 citations), Organic Chemistry (226 citations) and Molecular Biology (400 citations). Yangping Wu has collaborated with scholars based in China, United States and France. Frequent co-authors include Xi Chen, Jinliang Yang, Yuxi Wang, Qian Lei, Weimin Li, Qinhuai Lai, Benoı̂t Gigant, Qiang Chen, Yamei Yu and Hang Zhang. Their work appears in journals such as Journal of Molecular Medicine, Molecular Cancer, Signal Transduction and Targeted Therapy, Frontiers in Immunology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.